APP/PS1 double transgenic mice were used in this study which could cause earlier pathological manifestations such as Aβ sedimentation, senile plaques, neuronal loss, and behavioral obstacles of cognitive performance compared to single-transgenic mice, so that the length of the EA experiment cycle can be shortened. This evidence concerns the gene APP and Senile plaques.